Risks Remain for Endo (RealMoney.com $)
A lack of pipeline confidence could keep its valuation at a discount to peers.
01:25PM 01/09/07
Deals Boost Exelixis' Prospects (RealMoney.com $)
Two new deals solidify the company's research financing and cash position.
07:13AM 01/05/07
Rethinking the Case for Lilly (RealMoney.com $)
I'm still generally bullish on it, but my expectations have been deflated by recent developments.
03:12PM 12/28/06
Troubling Trends at PDL BioPharma
Several pillars of growth are starting to fade at PDL BioPharma.
11:43AM 12/22/06
Keep Par Pharma on the Watch List (RealMoney.com $)
It's still risky but may get more investible in early 2007.
07:59AM 12/19/06
Charles River Getting Back on Course
After an uneven year, positive guidance looks to give the company a boost.
03:37PM 12/15/06
Charles River Getting Back on Course (RealMoney.com $)
After an uneven year, positive guidance looks to give the company a boost.
03:06PM 12/14/06
Several product rollouts should prove to separate the winners and losers in this sector.
07:35AM 12/13/06
Beauty Stock Shakeout (RealMoney.com $)
Several product rollouts should prove to separate the winners and losers in this sector.
02:01PM 12/12/06
Mixed Outlook for Stent Makers (RealMoney.com $)
Here's how things are shaping up for the major players.
03:23PM 12/11/06


RSS Feed
Connect with TheStreet